Conceptio
›
Archive
›
ClinicalTrials.gov
ClinicalTrials.gov
public full text
Clinical Pharmacology of p38 MAP Kinase Inhibitor, VX-745, in Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD
EIP Pharma Inc
· 2015
ClinicalTrials.gov · Datasets · License: Public Domain · 2015
Open Source ↗
alzheimer-s-disease
alzheimer's disease, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Cessation of Somatostatin Analogues After PRRT in Mid, Hind-Gut and Pancreatic Neuroendocrine Tumours
#1048144
Chronicle Offers Management to Patients With Advanced Signs and Symptoms of Heart Failure (COMPASS-HF)
#1048145
Magic Camp for Children With Hemiplegic Cerebral Palsy
#1048147
Impact of Different Restorative Treatments for Deep Caries Lesion in Primary Teeth
#1048148
Continuous Lumbar Plexus Block for Postoperative Pain Control After Total Hip Arthroplasty
#1048152
Record
· ID 967318
Retrieved via
Conceptio
— every document is proof-bundled with source, license, and retrieval metadata.